MYDECINE

mydecine-logo

Mydecine is a vertically integrated company that utilizes medicinal, health, and wellness capabilities found in mycology. The Company, through its three divisions, “Mydecine Farms”, “Mydecine Wellness”, and “Psydecine Labs” aims to be an industry pioneer in the cultivation, processing, product development, and research and development of the many beneficial and exciting compounds that are found in various strains of mushroom and fungi from all around the world.

#SimilarOrganizations #People #Financial #Website #More

MYDECINE

Social Links:

Industry:
Health Care Wellness

Address:
Denver, Colorado, United States

Country:
United States

Website Url:
http://www.mydecine.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Euro Microsoft Exchange Online Office 365 Mail GoDaddy DNS GoDaddy SSL


Similar Organizations

rhode-island-free-clinic-logo

Rhode Island Free Clinic

Rhode Island Free Clinic is to provide free, comprehensive medical care and preventive health services to adults.

Current Employees Featured

josh-bartch_image

Josh Bartch
Josh Bartch Chief Executive Officer @ Mydecine
Chief Executive Officer
2020-03-01

not_available_image

Jim Gunning
Jim Gunning Chief Marketing Officer @ Mydecine
Chief Marketing Officer
2020-06-01

Founder


damon-michaels_image

Damon Michaels

Acquisitions List

Date Company Article Price
2020-05-21 Mindleap Mindleap acquired by Mydecine 4.5 M CAD

Official Site Inspections

http://www.mydecine.com Semrush global rank: 3.94 M Semrush visits lastest month: 3.17 K

  • Host name: a16e665f42988324c.awsglobalaccelerator.com
  • IP address: 13.248.243.5
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Mydecine"

Psilocybin and Mdma Drug Development - Mydecine Innovations …

Mydecine Innovations Group—a biotechnology company engineering the next wave of innovative medications and treatment protocols to address addiction and mental health.See details»

Our Company - Mydecine Innovations Group

Mydecine Innovations Group, a publicly traded pre-revenue biopharmaceutical company, launched in early 2020 with collaborators and staff members throughout North America and …See details»

Corporate Information - Mydecine Innovations Group

Mydecine - Certificate of Good Standing (pdf) Download. Listing Statement (pdf) Download. Information Circular (pdf) Download. 2013-09-27 - Certificate of Incorporation - (pdf) …See details»

Mydecine Innovations Group - LinkedIn

Mydecine Innovations Group™ (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) is a biotechnology company developing innovative first- and second-generation novel therapeutics for the treatment of mental health...See details»

Mydecine Innovations Group - Crunchbase Company Profile

Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders. They use a world-class technology and drug …See details»

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) …

Apr 5, 2022 · Mydecine is currently developing innovative first- and second-generation novel therapeutics to treat the unmet need in mental health and addiction disorders. The company …See details»

Mydecine Innovations Group - Psychedelic Science Review

Mydecine Innovations Group™ (MIG) is a start-up life sciences company focusing on mycology- (fungi) based psychedelic research, pharmaceutical/health products, and digital health solutions.See details»

Mydecine - Crunchbase Company Profile & Funding

Mydecine is a vertically integrated company that utilizes medicinal, health, and wellness capabilities found in mycology. The Company, through its three divisions, “Mydecine Farms”, …See details»

Mydecine Innovations Group Inc. - Canadian Securities Exchange

Mydecine Innovations Group Inc. is a publicly traded, pre-revenue biopharmaceutical company that began operations in North America and Europe in early 2020. Mydecine was founded to …See details»

Mydecine Innovations Group - YouTube

Mydecine Innovations Group™ is a biotechnology company developing first- and second-generation novel therapeutics to treat mental health and addiction disorders.See details»

Technology - Mydecine Innovations Group

Mydecine is developing a virtual drug development method that employs artificial intelligence and machine learning (AI/ML) to screen billions of novel compounds more quickly without the need …See details»

Mydecine Innovations Group Inc. (CSE: MYCO) (AQSE: MYIG) (OTC: …

Mydecine Innovations Group Inc. (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) is a biotechnology company developing innovative first- and second-generation novel therapeutics …See details»

Mydecine Innovations Group Announces Listing on the Canadian …

Mydecine utilizes cutting-edge artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them affordable …See details»

Mydecine Innovations Group Inc. Signs Partnership Agreement …

Jun 12, 2020 · Mydecine Innovations Group Inc. is the parent company operating innovative product divisions in the Naturally Sourced Therapies (NST) space.See details»

Mydecine Provides Q4 2023 Business Update - Yahoo Finance

Oct 26, 2023 · Mydecine Innovations Group is a publicly traded, pre-revenue biopharmaceutical company that began operations in North America and Europe in early 2020. Mydecine was …See details»

Our Approach - Mydecine Innovations Group

We have a robust portfolio of multiple pending patents for innovative first- and second-generation medications with a focus on safety and efficacy, as well as an excellent R&D staff and cutting …See details»

Mydecine Innovations Group Inc. (MYCO.CN) - Yahoo Finance …

Mydecine Innovations Group Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. …See details»

Mydecine Innovations Group Announces MYCO-001 Seamless

Sep 7, 2021 · Mydecine Innovations Group™ (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health …See details»

Mydecine Innovations Group Announces Common Share …

Aug 29, 2022 · Mydecine Innovations Group™ (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is a biotechnology company developing the next generation of innovative medications and …See details»

Contact - Mydecine Innovations Group

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.See details»

linkstock.net © 2022. All rights reserved